191 related articles for article (PubMed ID: 10622122)
1. [Search for new tuberculosis vaccines].
Gicquel B
Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122
[TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
5. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
[TBL] [Abstract][Full Text] [Related]
6. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.
Gupta A; Geetha N; Mani J; Upadhyay P; Katoch VM; Natrajan M; Gupta UD; Bhaskar S
Infect Immun; 2009 Jan; 77(1):223-31. PubMed ID: 18981249
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Mycobacterium bovis BCG.
Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
[TBL] [Abstract][Full Text] [Related]
10. Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.
Aguilar D; Infante E; Martin C; Gormley E; Gicquel B; Hernandez Pando R
Clin Exp Immunol; 2007 Feb; 147(2):330-8. PubMed ID: 17223975
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
12. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
13. Animal models for experimental tuberculosis.
Smith D; Wiegeshaus E; Balasubramanian V
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S68-70. PubMed ID: 11010825
[TBL] [Abstract][Full Text] [Related]
14. Immunoprophylaxis of tuberculosis: an update of emerging trends.
Singhal N; Bisht D; Joshi B
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):97-106. PubMed ID: 20140756
[TBL] [Abstract][Full Text] [Related]
15. What's new in tuberculosis vaccines?
Ginsberg AM
Bull World Health Organ; 2002; 80(6):483-8. PubMed ID: 12132007
[TBL] [Abstract][Full Text] [Related]
16. New tuberculosis vaccines.
Martín Montañés C; Gicquel B
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
[TBL] [Abstract][Full Text] [Related]
17. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
19. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine.
Wards BJ; de Lisle GW; Collins DM
Tuber Lung Dis; 2000; 80(4-5):185-9. PubMed ID: 11052907
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of cattle against Mycobacterium bovis.
Buddle BM
Tuberculosis (Edinb); 2001; 81(1-2):125-32. PubMed ID: 11463233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]